Clinical Trial

Enhancement of Stroke Rehabilitation With Levodopa

Study acronym: ESTREL
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg compared to placebo (given in addition to standardized rehabilitation based on the principles of motor learning) and whether there is an association with a patient-relevant enhancement of functional recovery in acute stroke patients. Study participants will be randomized 1:1.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2018-11-07; most recent amendment 2024-10-14.
Status change: Recruiting → Active, Not Recruiting 2024-10-14
Status change: Not Yet Recruiting → Recruiting 2019-06-17
Trial Details
NCT Number NCT03735901
Lead Sponsor University Hospital, Basel, Switzerland
Collaborators: Swiss National Science Foundation
Conditions Acute Stroke, Stroke Rehabilitation
Enrollment 610 participants
Start Date 2019-06-14
Primary Completion 2024-08-27 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-15